Literature DB >> 7546326

Determination of (R)- and (S)-salsolinol sulfate and dopamine sulfate levels in plasma of nonalcoholics and alcoholics.

H Rommelspacher1, S Sllström Baum, P Dufeu, L G Schmidt.   

Abstract

We have developed a new method to determine free as well as sulfoconjugated salsolinol (SAL), separated into both enantiomers, and free and sulfoconjugated dopamine in human blood plasma. Among the group of nonalcoholics (R)-SAL (mean +/- SEM: 0.24 +/- 0.07 ng/ml) was found in all blood samples and (S)-SAL in 1 out of 20 (0.08 ng/ml). Ethanol loading induced a rise of both enantiomers as well as of dopamine whereby (S)-SAL was detected in the plasma of 13 subjects only [(R)-SAL: 0.79 +/- 0.24 ng/ml; (S)-SAL: 0.49 +/- 0.15 ng/ml; DA: 8.84 +/- 0.75 ng/ml]. The later finding favors the notion of an enzymatic formation of (S)-SAL. In alcoholics, (R)-SAL and (S)-SAL were elevated at the day of admission for detoxification [(R)-SAL: 0.65 +/- 0.82 ng/ml; (S)-SAL: 0.35 +/- 0.05 ng/ml] and normalized after several months, suggesting intoxication marker characteristics [month 6: (R)-SAL: 0.24 +/- 0.14 ng/ml; (S)-SAL: 0.20 +/- 0.05 ng/ml]. Patients with alcoholic parents had lowered (R)-SAL and (S)-SAL levels compared with family history negative alcoholics, suggesting genetic association of disturbance of the SAL biosynthesis and alcoholism. Among the personality traits, suicidality was linked with low (R)-SAL and (S)-SAL concentrations in contrast to novelty seeking, impulsivity, and harm avoidance scores. The scores on the self-rating anxiety scale correlated positive with (R)-SAL. These findings suggest trait marker characteristics of salsolinol.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7546326     DOI: 10.1016/0741-8329(95)00004-b

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  8 in total

1.  Salsolinol stimulates dopamine neurons in slices of posterior ventral tegmental area indirectly by activating μ-opioid receptors.

Authors:  Guiqin Xie; Lucia Hipólito; Wanhong Zuo; Ana Polache; Luis Granero; Kresimir Krnjevic; Jiang-Hong Ye
Journal:  J Pharmacol Exp Ther       Date:  2011-12-30       Impact factor: 4.030

2.  A critical evaluation of influence of ethanol and diet on salsolinol enantiomers in humans and rats.

Authors:  Jeongrim Lee; Vijay A Ramchandani; Kei Hamazaki; Eric A Engleman; William J McBride; Ting-Kai Li; Hee-Yong Kim
Journal:  Alcohol Clin Exp Res       Date:  2009-11-24       Impact factor: 3.455

3.  Locomotor stimulant effects of acute and repeated intrategmental injections of salsolinol in rats: role of mu-opioid receptors.

Authors:  Lucía Hipólito; María-José Sánchez-Catalán; Teodoro Zornoza; Ana Polache; Luis Granero
Journal:  Psychopharmacology (Berl)       Date:  2010-03       Impact factor: 4.530

4.  Quantification of salsolinol enantiomers by stable isotope dilution liquid chromatography with tandem mass spectrometric detection.

Authors:  Min Cai; Yi-Ming Liu
Journal:  Rapid Commun Mass Spectrom       Date:  2008-12       Impact factor: 2.419

5.  Salsolinol modulation of dopamine neurons.

Authors:  Guiqin Xie; Krešimir Krnjević; Jiang-Hong Ye
Journal:  Front Behav Neurosci       Date:  2013-05-24       Impact factor: 3.558

6.  Salsolinol facilitates glutamatergic transmission to dopamine neurons in the posterior ventral tegmental area of rats.

Authors:  Guiqin Xie; Jiang-Hong Ye
Journal:  PLoS One       Date:  2012-05-10       Impact factor: 3.240

7.  Racemic Salsolinol and its Enantiomers Act as Agonists of the μ-Opioid Receptor by Activating the Gi Protein-Adenylate Cyclase Pathway.

Authors:  Pablo Berríos-Cárcamo; María E Quintanilla; Mario Herrera-Marschitz; Vasilis Vasiliou; Gerald Zapata-Torres; Mario Rivera-Meza
Journal:  Front Behav Neurosci       Date:  2017-01-23       Impact factor: 3.558

Review 8.  Acquisition, Maintenance and Relapse-Like Alcohol Drinking: Lessons from the UChB Rat Line.

Authors:  Yedy Israel; Eduardo Karahanian; Fernando Ezquer; Paola Morales; Marcelo Ezquer; Mario Rivera-Meza; Mario Herrera-Marschitz; María E Quintanilla
Journal:  Front Behav Neurosci       Date:  2017-04-04       Impact factor: 3.558

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.